Clinical Trials Logo

Asymptomatic Diseases clinical trials

View clinical trials related to Asymptomatic Diseases.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06395675 Not yet recruiting - Clinical trials for Chlamydia Trachomatis Infection

Clinical Evaluation of the ID NOW™ CT/NG Test

Start date: July 9, 2024
Phase: N/A
Study type: Interventional

The objective of this study is to determine the performance of the ID NOW™ CT/NG test in male urine, female urine, and self-collected vaginal swabs when tested by intended users (i.e., untrained operators). ID NOW™ CT/NG test results will be compared to results from up to three (3) FDA cleared CT/NG nucleic acid amplification tests (NAATs) for each sample type.

NCT ID: NCT05911828 Not yet recruiting - Falciparum Malaria Clinical Trials

A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers

Start date: August 1, 2024
Phase: Phase 1
Study type: Interventional

Malaria is caused by protozoan parasites of the genus Plasmodium and it is the most important parasitic disease in terms of mortality and morbidity. Estimates of 247 million malaria cases and 619.000 deaths worldwide were reported by WHO for the year 2021 (1). Plasmodium falciparum can lead to severe malaria and accounts for 90% of malaria deaths that mainly occur in children below the age of 5 years in Sub-Saharan Africa. A simplified treatment regimen, ideally a single-day cure (or at most 2-day dosing regimen), of uncomplicated malaria due to P. falciparum would be the magic in the antimalarial armamentarium. Improving treatment adherence is one of the key factors in reducing mortality and morbidity and also the transmission of malaria, and such a regimen would substantially increase adherence. To find a new non-artemisinin combination therapy with a shorter regimen, ideally, a single-dose cure, with low resistance potential would be the aim. The two compounds tested here are ZY19489, a triaminopyrimidine, and ferroquine (FQ), a next-generation 4-aminoquinoline. Both compounds show unique features in terms of long half-life, and activity against current drug-resistant strains. Therefore, the main goal of this clinical trial is to assess the safety of the ZY19489-FQ combination given as a 1- or 2-day dose regimen.

NCT ID: NCT02740647 Not yet recruiting - Clinical trials for Asymptomatic Diseases

The Efficiency of Postoperative Antibiotics in Orthognathic Surgery

Start date: April 2016
Phase: N/A
Study type: Interventional

Orthognathic surgery is the state of art of the maxillofacial surgery, it fix and normalize facial abnormalities and create a harmony between the different tissues compounding the face (bone, soft tissue and dental structures). It is a common procedure and it is done in order to correct a dentofacial and skeletal deformities. There is an inevitable risk of complications with this type of surgery. While postoperative infections are the most common complication (2% to 33.4%). preoperative administration of antibiotics have been proven to be effective in reducing the postoperative infection rate, while, the quality of the currently available literature in prescribing continues postoperative antibiotics is questionable and there is still no consensus on its efficacy. Unwise administration of antibiotics may cause several unwanted side effects such as gastrointestinal symptoms, allergy reactions, high costs, etc… while the most worrisome side effect is a bacterial resentence. The objective of this study is to investigate the efficacy of postoperative antibiotics. And will try to state a consensus in prescribing postoperative antibiotics. By conducting a prospective, randomized, double-blind, placebo-controlled study, that will explore and analyze the efficacy of postoperative administration of Amoxicillin Clavulanate versus placebo in reducing the rate of postoperative infections in 60 healthy patients.

NCT ID: NCT02238028 Not yet recruiting - Inflammation Clinical Trials

Intervention Study on the Health Effects of Wearing Particulate Filtering Respirators

Start date: November 2014
Phase: N/A
Study type: Interventional

An intervention study to assess the cardiovascular and respiratory effects of reducing personal air pollution exposure by wearing particulate filtering respirators.